The role of IL‐33 and mast cells in allergy and inflammation
Open accessThe DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Abstract
Interleukin‐33 (IL‐33) is a member of the interleukin‐1 (IL‐1) cytokine family. It is preferentially and constitutively expressed in different structural cells such as epithelial cells, endothelial cells, and smooth muscle cells. During necrosis of these cells (after tissue injury or cell damage), the IL‐33 that is released may be recognized by different types of immune cells, such as eosinophils, basophils and, especially, mast cells. IL‐33 needs the specific receptor ST2 (membrane‐bound receptor) and Interleukin‐1 receptor accessory protein heterodimer for its binding, which instigates the production of different types of cytokines and chemokines that have crucial roles in the exacerbation of allergic diseases and inflammation. IL‐33 and mast cells have been influentially associated to the pathophysiology of allergic diseases and inflammation. IL‐33 is a crucial regulator of mast cell functions and might be an attractive therapeutic target for the treatment of allergic and inflammatory diseases. In this review, we summarize the current knowledge regarding the roles of IL‐33 and mast cells in the pathogenesis of allergies and inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calamita, E., Schmid, M., Kunz, M., Ndebele-Murisa, M. R., Magadza, C. H. D., Nyambe, I., & Wehrli, B. (2019) · Figshare · doi:10.26181/6153922fe919c · Cited by 4,222
Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.015 · Cited by 3,710
Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells
Moro, K., Yamada, T., Tanabe, M., Takeuchi, T., Ikawa, T., Kawamoto, H., Furusawa, J.-I., Ohtani, M., Fujii, H., & Koyasu, S. (2010) · Nature · doi:10.1038/nature08636 · Cited by 1,992
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
Neill, D. R., Wong, S. H., Bellosi, A., Flynn, R. J., Daly, M., Langford, T. K. A., Bucks, C., Kane, C. M., Fallon, P. G., Pannell, R., et al. (2010) · Nature · doi:10.1038/nature08900 · Cited by 1,938 · cited 2×
“The type 2 (ILC2) innate lymphoid cells localized in mucosal tissues (lung and intestine), adipose tissue and lymphoid organs (spleen, lymph node) are the major target cells of IL-33 [12, 24, 25].”
BackgroundMoussion, C., Ortega, N., & Girard, J.-P. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003331 · Cited by 1,179 · cited 3×
“Human Protein Endothelial cells and epithelial cells, Lymphoid tissues, keratinocytes and stomach (epithelial cells) [7]”
BackgroundMjösberg, J. M., Trifari, S., Crellin, N. K., Peters, C. P., van Drunen, C. M., Piet, B., Fokkens, W. J., Cupedo, T., & Spits, H. (2011) · Nature Immunology · doi:10.1038/ni.2104 · Cited by 1,166 · cited 1×
“The type 2 (ILC2) innate lymphoid cells localized in mucosal tissues (lung and intestine), adipose tissue and lymphoid organs (spleen, lymph node) are the major target cells of IL-33 [12, 24, 25].”
BackgroundSystemically dispersed innate IL-13–expressing cells in type 2 immunity
Price, A. E., Liang, H.-E., Sullivan, B. M., Reinhardt, R. L., Eisley, C. J., Erle, D. J., & Locksley, R. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003988107 · Cited by 1,131 · cited 1×
“Later, it was reported that IL-33 also plays an important role in innate immune responses, for example during influenza virus infections in the lungs [11] and in helminth infections in the intestine [12, 13].”
BackgroundDisease-associated functions of IL-33: the new kid in the IL-1 family
Liew, F. Y., Pitman, N. I., & McInnes, I. B. (2010) · Nature Reviews Immunology · doi:10.1038/nri2692 · Cited by 1,003 · cited 2×
“ST2 receptor has two major isoforms: a transmembrane form (ST2 or ST2L) and a soluble form (sST2) [2].”
BackgroundA role for IL-25 and IL-33–driven type-2 innate lymphoid cells in atopic dermatitis
Salimi, M., Barlow, J. L., Saunders, S. P., Xue, L., Gutowska-Owsiak, D., Wang, X., Huang, L.-C., Johnson, D., Scanlon, S. T., McKenzie, A. N. J., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130351 · Cited by 979 · cited 1×
“IL-33 is also an effective stimulator for skin ILC2s, and it is directly associated with skin inflammation and mouse model of atopic dermatitis [23].”
BackgroundCarriere, V., Roussel, L., Ortega, N., Lacorre, D.-A., Americh, L., Aguilar, L., Bouche, G., & Girard, J.-P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606854104 · Cited by 966 · cited 2×
“It consists of N-terminal helix-turn-helix (HTH) motif responsible for nuclear translocation and chromatin binding [6] and an IL-1-like C-terminal domain, which is cleaved by caspase 1 to form an active 18 kDa mature peptide [28, 34, 35].”
BackgroundHalim, T. Y. F., Steer, C. A., Mathä, L., Gold, M. J., Martinez-Gonzalez, I., McNagny, K. M., McKenzie, A. N. J., & Takei, F. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.011 · Cited by 949 · cited 1×
“Moreover, Th2 cell differentiation and eosinophilic lung inflammation were found to be impaired in intranasally challenged IL33-deficient mice [18, 19].”
BackgroundChen, C.-J., Kono, H., Golenbock, D., Reed, G., Akira, S., & Rock, K. L. (2007) · Nature Medicine · doi:10.1038/nm1603 · Cited by 876 · cited 1×
“Release of IL‐33 Interleukin-33 is stored in the nucleus and secreted upon necrosis or damage and released in response to cell injury, infection or mechanical damage [27, 28].”
BackgroundChang, Y.-J., Kim, H. Y., Albacker, L. A., Baumgarth, N., McKenzie, A. N. J., Smith, D. E., DeKruyff, R. H., & Umetsu, D. T. (2011) · Nature Immunology · doi:10.1038/ni.2045 · Cited by 777 · cited 1×
“Later, it was reported that IL-33 also plays an important role in innate immune responses, for example during influenza virus infections in the lungs [11] and in helminth infections in the intestine [12, 13].”
BackgroundThe IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1
Cayrol, C., & Girard, J.-P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812690106 · Cited by 707 · cited 3×
“The processing of IL-33 by caspases results in its inactivation [28, 35].”
BackgroundIL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy
Cayrol, C., & Girard, J.-P. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.09.004 · Cited by 699 · cited 1×
“IL-33 also plays a crucial roles in the initiation as well as amplification of a type 2 response in group 2 innate lymphoid cells (ILC2s) [17].”
BackgroundSuppression of Interleukin-33 Bioactivity through Proteolysis by Apoptotic Caspases
Lüthi, A. U., Cullen, S. P., McNeela, E. A., Duriez, P. J., Afonina, I. S., Sheridan, C., Brumatti, G., Taylor, R. C., Kersse, K., Vandenabeele, P., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.007 · Cited by 677 · cited 1×
“It consists of N-terminal helix-turn-helix (HTH) motif responsible for nuclear translocation and chromatin binding [6] and an IL-1-like C-terminal domain, which is cleaved by caspase 1 to form an active 18 kDa mature peptide [28, 34, 35].”
BackgroundThe role of neutrophils during intestinal inflammation
Fournier, B. M., & Parkos, C. A. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.24 · Cited by 671 · cited 1×
“It has also been shown that serine proteases released by inflammatory cells play a critical role in the generation of super active forms of IL-33 and enhance immune response in asthma, rheumatoid arthritis, intestinal inflammation and other diseases [40, 41].”
BackgroundBartemes, K. R., Iijima, K., Kobayashi, T., Kephart, G. M., McKenzie, A. N., & Kita, H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102832 · Cited by 549
Soluble ST2 Blocks Interleukin-33 Signaling in Allergic Airway Inflammation
Hayakawa, H., Hayakawa, M., Kume, A., & Tominaga, S.-I. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704916200 · Cited by 546
Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells
Préfontaine, D., Lajoie-Kadoch, S., Foley, S., Audusseau, S., Olivenstein, R., Halayko, A. J., Lemière, C., Martin, J. G., & Hamid, Q. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802387 · Cited by 538 · cited 1×
“Interleukin-33 expression was found to be increased in several pathological conditions such as airway smooth muscle cell [14] and lung epithelial cells of asthmatic patients [9] as well as in airway epithelial cells in COPD patients [15].”
BackgroundIL-1 Receptor Accessory Protein and ST2 Comprise the IL-33 Receptor Complex
Chackerian, A. A., Oldham, E. R., Murphy, E. E., Schmitz, J., Pflanz, S., & Kastelein, R. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2551 · Cited by 508 · cited 1×
“In an in vivo model, mice deficient either in IL-1RAcP or ST2 did not show an inflammatory reaction in response to IL-33 administration [42].”
BackgroundKouzaki, H., Iijima, K., Kobayashi, T., O’Grady, S. M., & Kita, H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003020 · Cited by 495 · cited 1×
“[33] found that exposing the human airway epithelial cells to A.”
BackgroundRole of IL-33 in inflammation and disease
Miller, A. M. (2011) · Journal of Inflammation · doi:10.1186/1476-9255-8-22 · Cited by 481
Kondo, Y., Yoshimoto, T., Yasuda, K., Futatsugi-Yumikura, S., Morimoto, M., Hayashi, N., Hoshino, T., Fujimoto, J., & Nakanishi, K. (2008) · International Immunology · doi:10.1093/intimm/dxn037 · Cited by 478
Pichery, M., Mirey, E., Mercier, P., Lefrancais, E., Dujardin, A., Ortega, N., & Girard, J.-P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101977 · Cited by 466 · cited 3×
“conditions Interleukin-33 transcript and protein is widely expressed in different cell types including in cells of both hematopoietic as well as non-hematopoietic origin such as macrophages, dendritic cells, fibroblasts, adipocytes, smooth muscle cells, endothelial cells, bronchial, osteoblast and intestinal epithelia…”
BackgroundInfluentialIL-33 exacerbates antigen-induced arthritis by activating mast cells
Xu, D., Jiang, H.-R., Kewin, P., Li, Y., Mu, R., Fraser, A. R., Pitman, N., Kurowska-Stolarska, M., McKenzie, A. N. J., McInnes, I. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801898105 · Cited by 464 · cited 1×
“Research from several studies has indicated that IL-33 also acts as a potent activator of mast cells and basophils and reported to induce migration, maturation, adhesion, promote survival and the production of several pro-inflammatory cytokines in these cells [44, 49–51].”
BackgroundKurowska-Stolarska, M., Kewin, P., Murphy, G., Russo, R. C., Stolarski, B., Garcia, C. C., Komai-Koma, M., Pitman, N., Li, Y., McKenzie, A. N. J., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4780 · Cited by 460 · cited 5×
“It has also been reported that IL-33 can activate MCs [46], and act directly on Th2 cells to increase secretion of Th2 cytokines such as IL-5 and IL-13 [5, 47].”
BackgroundInfluentialIncreased IL-33 expression by epithelial cells in bronchial asthma
Préfontaine, D., Nadigel, J., Chouiali, F., Audusseau, S., Semlali, A., Chakir, J., Martin, J. G., & Hamid, Q. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.12.935 · Cited by 454 · cited 2×
“Interleukin-33 expression was found to be increased in several pathological conditions such as airway smooth muscle cell [14] and lung epithelial cells of asthmatic patients [9] as well as in airway epithelial cells in COPD patients [15].”
BackgroundImai, Y., Yasuda, K., Sakaguchi, Y., Haneda, T., Mizutani, H., Yoshimoto, T., Nakanishi, K., & Yamanishi, K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307321110 · Cited by 431
IL-33 and ST2 in Atopic Dermatitis: Expression Profiles and Modulation by Triggering Factors
Savinko, T., Matikainen, S., Saarialho-Kere, U., Lehto, M., Wang, G., Lehtimäki, S., Karisola, P., Reunala, T., Wolff, H., Lauerma, A., et al. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.446 · Cited by 387
Coyle, A. J., Lloyd, C., Tian, J., Nguyen, T., Erikkson, C., Wang, L., Ottoson, P., Persson, P., Delaney, T., Lehar, S., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.7.895 · Cited by 370
IL-33 can promote survival, adhesion and cytokine production in human mast cells
Iikura, M., Suto, H., Kajiwara, N., Oboki, K., Ohno, T., Okayama, Y., Saito, H., Galli, S. J., & Nakae, S. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700663 · Cited by 370 · cited 1×
“Research from several studies has indicated that IL-33 also acts as a potent activator of mast cells and basophils and reported to induce migration, maturation, adhesion, promote survival and the production of several pro-inflammatory cytokines in these cells [44, 49–51].”
BackgroundLong-term IL-33–producing epithelial progenitor cells in chronic obstructive lung disease
Byers, D. E., Alexander-Brett, J., Patel, A. C., Agapov, E., Dang-Vu, G., Jin, X., Wu, K., You, Y., Alevy, Y., Girard, J.-P., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65570 · Cited by 337 · cited 1×
“Interleukin-33 expression was found to be increased in several pathological conditions such as airway smooth muscle cell [14] and lung epithelial cells of asthmatic patients [9] as well as in airway epithelial cells in COPD patients [15].”
BackgroundInflammasome-independent regulation of IL-1-family cytokines
Netea, M. G., van de Veerdonk, F. L., van der Meer, J. W. M., Dinarello, C. A., & Joosten, L. A. B. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112306 · Cited by 326 · cited 1×
“The IL-1 family members do not possess signal peptide to release the proteins via endoplasmic reticulum and Golgi pathway [29].”
BackgroundIL-33 Exacerbates Eosinophil-Mediated Airway Inflammation
Stolarski, B., Kurowska-Stolarska, M., Kewin, P., Xu, D., & Liew, F. Y. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000730 · Cited by 291
IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcεRI signals
Ho, L. H., Ohno, T., Oboki, K., Kajiwara, N., Suto, H., Iikura, M., Okayama, Y., Akira, S., Saito, H., Galli, S. J., et al. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0407200 · Cited by 285
Interleukin-33 Is Biologically Active Independently of Caspase-1 Cleavage
Talabot-Ayer, D., Lamacchia, C., Gabay, C., & Palmer, G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901744200 · Cited by 252 · cited 2×
“The processing of IL-33 by caspases results in its inactivation [28, 35].”
BackgroundNeutrophils in rheumatoid arthritis: More than simple final effectors
Cascão, R., Rosário, H. S., Souto-Carneiro, M. M., & Fonseca, J. E. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.12.013 · Cited by 245 · cited 1×
“It has also been shown that serine proteases released by inflammatory cells play a critical role in the generation of super active forms of IL-33 and enhance immune response in asthma, rheumatoid arthritis, intestinal inflammation and other diseases [40, 41].”
BackgroundA critical role of IL-33 in experimental allergic rhinitis
Haenuki, Y., Matsushita, K., Futatsugi-Yumikura, S., Ishii, K. J., Kawagoe, T., Imoto, Y., Fujieda, S., Yasuda, M., Hisa, Y., Akira, S., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.02.013 · Cited by 233 · cited 1×
“IL-33 also seems to be essential for development of allergic rhinitis induced by ragweed pollen challenge as IL-33 knockout mice failed to induce ragweed pollen induce allergic rhinitis [22].”
BackgroundKearley, J., Buckland, K. F., Mathie, S. A., & Lloyd, C. M. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200805-666oc · Cited by 227
Production and functions of IL-33 in the central nervous system
Yasuoka, S., Kawanokuchi, J., Parajuli, B., Jin, S., Doi, Y., Noda, M., Sonobe, Y., Takeuchi, H., Mizuno, T., & Suzumura, A. (2011) · Brain Research · doi:10.1016/j.brainres.2011.02.045 · Cited by 222 · cited 2×
“Mice Transcript Glial cells, astrocytes [1]”
BackgroundAnti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma
Liu, X., Li, M., Wu, Y., Zhou, Y., Zeng, L., & Huang, T. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.008 · Cited by 219
Mast Cells as Sensors of Cell Injury through IL-33 Recognition
Enoksson, M., Lyberg, K., Möller-Westerberg, C., Fallon, P. G., Nilsson, G., & Lunderius-Andersson, C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003383 · Cited by 218
Lingel, A., Weiss, T. M., Niebuhr, M., Pan, B., Appleton, B. A., Wiesmann, C., Bazan, J. F., & Fairbrother, W. J. (2009) · Structure · doi:10.1016/j.str.2009.08.009 · Cited by 212
IL-33 and IL-33 receptors in host defense and diseases
Oboki, K., Ohno, T., Kajiwara, N., Saito, H., & Nakae, S. (2010) · Allergology International · doi:10.2332/allergolint.10-rai-0186 · Cited by 190 · cited 1×
“Further studies have shown that IL-33 not only activates mast cells, but also other immune cells, such as granulocytes, macrophages, NK and Th2 cells [26].”
BackgroundFunctional SNPs in the distal promoter of the ST2 gene are associated with atopic dermatitis
Shimizu, M., Matsuda, A., Yanagisawa, K., Hirota, T., Akahoshi, M., Inomata, N., Ebe, K., Tanaka, K., Sugiura, H., Nakashima, K., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi323 · Cited by 186
IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes
Wood, I. S., Wang, B., & Trayhurn, P. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.04.081 · Cited by 182 · cited 1×
“[8] studied the Open Access”
Kay, A. B., Clark, P., Maurer, M., & Ying, S. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13621 · Cited by 171 · cited 1×
“Human Protein Skin [71]”
Self-citationMATSUYAMA, Y., OKAZAKI, H., TAMEMOTO, H., KIMURA, H., KAMATA, Y., NAGATANI, K., NAGASHIMA, T., HAYAKAWA, M., IWAMOTO, M., YOSHIO, T., et al. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.090492 · Cited by 169 · cited 1×
“Extracellular IL-33 has also been detected in human blood and synovial fluids in pathological conditions [31], where cells have been damaged (during rheumatoid arthritis or infection with influenza virus, respectively) and in mouse peritoneal and bronchoalveolar lavage fluid [32].”
BackgroundKamijo, S., Takeda, H., Tokura, T., Suzuki, M., Inui, K., Hara, M., Matsuda, H., Matsuda, A., Oboki, K., Ohno, T., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201212 · Cited by 166 · cited 1×
“Moreover, Th2 cell differentiation and eosinophilic lung inflammation were found to be impaired in intranasally challenged IL33-deficient mice [18, 19].”
BackgroundKaur, D., Gomez, E., Doe, C., Berair, R., Woodman, L., Saunders, R., Hollins, F., Rose, F. R., Amrani, Y., May, R., et al. (2015) · Allergy · doi:10.1111/all.12593 · Cited by 166 · cited 1×
“Human Transcript and protein Airway smooth muscle (ASM), bronchial epithelium [62]”
BackgroundCaspase-1, Caspase-8, and Calpain Are Dispensable for IL-33 Release by Macrophages
Ohno, T., Oboki, K., Kajiwara, N., Morii, E., Aozasa, K., Flavell, R. A., Okumura, K., Saito, H., & Nakae, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802449 · Cited by 159 · cited 1×
“Later, it was confirmed that IL-33 protein contains the cleavage sites for caspase-3 and caspase-7 and it can be expressed and released by activated macrophages [36].”
BackgroundDemyanets, S., Kónya, V., Kastl, S., Kaun, C., Rauscher, S., Niessner, A., Pentz, R., Pfaffenberger, S., Rychli, K., Lemberger, C. E., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.231431 · Cited by 156 · cited 2×
“Human Transcript and protein Human adult cardiac fibroblasts (HACF) and human adult cardiac myocytes (HACM) [68]”
BackgroundSchneider, E., Petit-Bertron, A.-F., Rignault‐Bricard, R., Levasseur, M., Ramadan, A., Girard, J., Herbelin, A., & Dy, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900328 · Cited by 152 · cited 1×
“Research from several studies has indicated that IL-33 also acts as a potent activator of mast cells and basophils and reported to induce migration, maturation, adhesion, promote survival and the production of several pro-inflammatory cytokines in these cells [44, 49–51].”
BackgroundRoy, A., Ganesh, G., Sippola, H., Bolin, S., Sawesi, O., Dagälv, A., Schlenner, S., Feyerabend, T. B., Rodewald, H.-R., Kjellén, L., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.435156 · Cited by 145 · cited 1×
“[39] reported that mast cell chymase but not tryptase cleaves IL-33 and results in increased bioactivity.”
BackgroundKomai‐Koma, M., Brombacher, F., Pushparaj, P. N., Arendse, B., McSharry, C., Alexander, J., Chaudhuri, R., Thomson, N. C., McKenzie, A. N. J., McInnes, I., et al. (2012) · Allergy · doi:10.1111/j.1398-9995.2012.02859.x · Cited by 142 · cited 1×
“Furthermore, IL-33 functions as a chemoattractant for Th2 cells [48].”
BackgroundInfection with Influenza Virus Induces IL-33 in Murine Lungs
Goffic, R. L., Arshad, M. I., Rauch, M., L’Helgoualc’h, A., Delmas, B., Piquet‐Pellorce, C., & Samson, M. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0516oc · Cited by 142 · cited 6×
“Human Transcript Human epithelial cells (A549) [32]”
BackgroundInfluentialExpression and function of the ST2 gene in a murine model of allergic airway inflammation
Oshikawa, K., Yanagisawa, K., Tominaga, S., & Sugiyama, Y. (2002) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2745.2002.01494.x · Cited by 142
TRAF6 is a critical signal transducer in IL-33 signaling pathway
Funakoshi‐Tago, M., Tago, K., Hayakawa, M., Tominaga, S., Ohshio, T., Sonoda, Y., & Kasahara, T. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.05.013 · Cited by 141 · cited 1×
“IL-33 binding by the ST2 receptor leads to the activation and recruitment of MyD88 adapter protein along with IL-1R-associated kinase1 (IRAK1), IRAK4 and TNFR-associated factor 6 (TRAF6) [5, 43].”
BackgroundLouten, J., Rankin, A. L., Li, Y., Murphy, E. E., Beaumont, M., Moon, C., Bourne, P., McClanahan, T. K., Pflanz, S., & de Waal Malefyt, R. (2011) · International Immunology · doi:10.1093/intimm/dxr006 · Cited by 132 · cited 1×
“IL-33 is the essential factor for severe allergic lung inflammation [20].”
BackgroundBlockade of IL-33/ST2 ameliorates airway inflammation in a murine model of allergic asthma
Lee, H., Rhee, C. K., Kang, J. Y., Byun, J. H., Choi, J. Y., Kim, S. J., Kim, Y. K., Kwon, S. S., & Lee, S. Y. (2014) · Experimental Lung Research · doi:10.3109/01902148.2013.870261 · Cited by 129
Meephansan, J., Tsuda, H., Komine, M., Tominaga, S., & Ohtsuki, M. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.185 · Cited by 128
The role of the IL-33/IL-1RL1 axis in mast cell and basophil activation in allergic disorders
Saluja, R., Ketelaar, M. E., Hawro, T., Church, M. K., Maurer, M., & Nawijn, M. C. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.06.018 · Cited by 122 · cited 1×
“MyD88 is crucial for several functional responses to IL-33 such as survival cytokine production and MCs proliferation [44, 45].”
BackgroundSelf-citationIL-33: A Novel Danger Signal System in Atopic Dermatitis
Cevikbas, F., & Steinhoff, M. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.66 · Cited by 113
Lefrançais, E., & Cayrol, C. (2012) · European Cytokine Network · doi:10.1684/ecn.2012.0320 · Cited by 107 · cited 2×
“These cleaved IL-33 forms have 10 times greater potency than the full-length protein [38].”
Backgroundde Andrade, M. V. M., Iwaki, S., Ropert, C., Gazzinelli, R. T., Cunha-Melo, J. R., & Beaven, M. A. (2011) · European Journal of Immunology · doi:10.1002/eji.201040718 · Cited by 93
Nuclear expression of interleukin-33 in pancreatic stellate cells
Masamune, A., Watanabe, T., Kikuta, K., Satoh, K., Kanno, A., & Shimosegawa, T. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00178.2010 · Cited by 86 · cited 3×
“Mice Transcript and protein Pancreas [69]”
The Role of Interleukin-33 in Chronic Allergic Conjunctivitis
Matsuda, A., Okayama, Y., Terai, N., Yokoi, N., Ebihara, N., Tanioka, H., Kawasaki, S., Inatomi, T., Katoh, N., Ueda, E., et al. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-3365 · Cited by 84
Special aspects of interleukin-33 and the IL-33 receptor complex
Martin, M. U. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.006 · Cited by 83 · cited 1×
“released immediately during emergency conditions such as infection, injury or inflammation due to other stressors [30].”
BackgroundIL-33 induces Th17-mediated airway inflammation via mast cells in ovalbumin-challenged mice
Cho, K., Suh, J. W., Sohn, J.-H., Park, J., Lee, H., Kang, J. L., Woo, S., & Cho, Y.-J. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00252.2011 · Cited by 83
Serum levels of IL-10, IL-17F and IL-33 in patients with asthma: a case–control study
Jahromi, S. R., Mahesh, P. A., Siddaiah, J. B., Madhunapantula, S. V., Holla, A. D., Vishweswaraiah, S., & Ramachandra, N. B. (2014) · Journal of Asthma · doi:10.3109/02770903.2014.938353 · Cited by 76
TRAIL but not FasL and TNFα, regulates IL-33 expression in murine hepatocytes during acute hepatitis
Arshad, M. I., Piquet‐Pellorce, C., L’Helgoualc’h, A., Rauch, M., Patrat-Delon, S., Ezan, F., Lucas‐Clerc, C., Nabti, S., Lehuen, A., Cubero, F. J., et al. (2012) · Hepatology · doi:10.1002/hep.25893 · Cited by 75
Tjota, M. Y., Hrusch, C. L., Blaine, K. M., Williams, J. W., Barrett, N. A., & Sperling, A. I. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.06.013 · Cited by 59
Interleukin‐33 exacerbates allergic bronchoconstriction in the mice via activation of mast cells
Sjöberg, L., Gregory, J. A., Dahlén, S., Nilsson, G. P., & Adner, M. (2015) · Allergy · doi:10.1111/all.12590 · Cited by 59
Murine Mast Cells Secrete and Respond to Interleukin-33
Tung, H.-Y., Plunkett, B., Huang, S.-K., & Zhou, Y. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2012.0066 · Cited by 48
Yang, Z., Sun, R., Grinchuk, V., Fernández-Blanco, J. A., Notari, L., Bohl, J. A., McLean, L. P., Ramalingam, T. R., Wynn, T. A., Urban, J. F., et al. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00357.2012 · Cited by 43
Saluja, R., Hawro, T., Eberle, J., Church, M. K., & Maurer, M. (2014) · PubMed · Cited by 36
Self-citationAndronicos, N. M., McNally, J., Kotze, A. C., Hunt, P. W., & Ingham, A. B. (2012) · International Journal for Parasitology · doi:10.1016/j.ijpara.2012.01.007 · Cited by 29 · cited 1×
“[10] established that damage caused by motile gastrointestinal nematode larvae in parasitic infection significantly induced IL-33 mRNA expression in epithelial cells.”
BackgroundIL-33/ST2 involves the immunopathology of ocular toxoplasmosis in murine model
Tong, X., & Lü, F. (2015) · Parasitology Research · doi:10.1007/s00436-015-4377-3 · Cited by 19 · cited 1×
“Mice Transcript and protein Eye and cervical lymph nodes (CLNs) [72]”
BackgroundExpression of interleukin‐33 and its receptor ST 2 in periapical granulomas and radicular cysts
Velickovic, M., Pejnovic, N. N., Petrović, R., Mitrović, S., Jeftic, I. D., Kanjevac, T., & Lukić, A. (2015) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12312 · Cited by 14 · cited 1×
“Human Protein Fibroblast [70]”
Cited by
The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases
Griesenauer, B., & Paczesny, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00475 · Cited by 619
The role and relevance of mast cells in urticaria
Church, M. K., Kolkhir, P., Metz, M., & Maurer, M. (2018) · Immunological Reviews · doi:10.1111/imr.12632 · Cited by 295
Self-citationIgE and mast cells in host defense against parasites and venoms
Mukai, K., Tsai, M., Starkl, P., Marichal, T., & Galli, S. J. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0565-1 · Cited by 202
Ball, D. H., Al-Riyami, L., Harnett, W., & Harnett, M. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-22716-9 · Cited by 197
Brunner, P. M., He, H., Pavel, A. B., Czarnowicki, T., Lefferdink, R., Erickson, T., Canter, T., Puar, N., Rangel, S. M., Malik, K., et al. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.04.036 · Cited by 109
Metadata
- Authors
- Saluja, R., Khan, M., Church, M. K., & Maurer, M.
- Venue
- Clinical and Translational Allergy
- Publisher
- Wiley
- Published
- 2015-01
- Volume
- 5
- Issue
- 1
- Pages
- 33-33
- ISSN
- 2045-7022 (ISSN-L)
- OpenAlex
- W1783260908
- Cited by
- 197
- References
- 80
- FWCI
- 10.31
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.